KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Castle Biosciences (CSTL) Cash from Investing Activities (2018 - 2025)

Historic Cash from Investing Activities for Castle Biosciences (CSTL) over the last 8 years, with Q3 2025 value amounting to -$18.4 million.

  • Castle Biosciences' Cash from Investing Activities fell 2434.24% to -$18.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$63.4 million, marking a year-over-year increase of 23.75%. This contributed to the annual value of -$50.1 million for FY2024, which is 20981.28% down from last year.
  • Castle Biosciences' Cash from Investing Activities amounted to -$18.4 million in Q3 2025, which was down 2434.24% from -$28.4 million recorded in Q2 2025.
  • Castle Biosciences' Cash from Investing Activities' 5-year high stood at $16.6 million during Q1 2023, with a 5-year trough of -$134.2 million in Q3 2022.
  • Over the past 5 years, Castle Biosciences' median Cash from Investing Activities value was -$15.4 million (recorded in 2023), while the average stood at -$19.4 million.
  • Its Cash from Investing Activities has fluctuated over the past 5 years, first crashed by 1443412.78% in 2022, then surged by 422537.31% in 2023.
  • Castle Biosciences' Cash from Investing Activities (Quarter) stood at -$30.9 million in 2021, then skyrocketed by 85.49% to -$4.5 million in 2022, then plummeted by 71.17% to -$7.7 million in 2023, then soared by 175.21% to $5.8 million in 2024, then crashed by 418.7% to -$18.4 million in 2025.
  • Its Cash from Investing Activities stands at -$18.4 million for Q3 2025, versus -$28.4 million for Q2 2025 and -$22.4 million for Q1 2025.